Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Starts Diamondrock Hospitality (DRH) at Buy
-
Canaccord Genuity Starts Strategic Hotels & Resorts (BEE) at Buy
-
Canaccord Genuity Starts Ashford Hospitality Trust (AHT) at Buy
-
Vermillion (VRML) Plans Public Offering of Common Stock
-
Vermillion, Inc. Announces Proposed Public Offering of Common Stock
-
Orsu Metals Corporation: Notification of Holding in Company
-
Canaccord Genuity Maintains a Hold Rating on AeroVironment (AVAV) Following Analyst Day Presentations
-
Baytex Confirms Monthly Dividend for July at $0.10 Per Share
-
Meadow Bay Gold Closes Funding
-
Notable Analyst Rating Changes 7/10: (COST) (RIO) (AGI) Upgraded; (CRL) (IAG) (RAX) Downgraded
-
Canaccord Genuity Remains Bullish as Black Diamond (BDE) Enters Final Stages of Sale Process
-
ATARA Biotherapeutics (ATRA) Prices 3.46M Common Stock Offeirng at $52/Share
-
Canaccord Genuity Upgrades Alamos Gold (AGI) to Buy
-
Atara Bio Announces Pricing of Its $180.0 Million Offering of Common Stock
-
EMED Mining Public Limited Announces Management Update
-
UPDATE: GenSight Biologics S.A. (GNST) Files $100M Common Stock IPO
-
EnteroMedics Inc. Announces Closing of $16.0 Million Public Offering of Common Stock and Warrants
-
Dr. Adam Walsh to Join Stifel Healthcare Equity Research Team
-
PlacementTracker Publishes First Half 2015 PIPE Market League Tables
-
UPDATE: Canaccord Genuity Initiates Healthcare REITs With Positive Sector Outlook (HCN) (SNR) (CTRE) (DOC) (LTC)
-
Canaccord Genuity Cuts Price Target on Qualcomm (QCOM) Following Weak Android Smartphone Sales
-
Canaccord Genuity Starts Sabra Healthcare REIT Inc. (SBRA) at Hold
-
Canaccord Genuity Starts BioMed Realty (BMR) at Hold
-
Canaccord Genuity Starts LTC Properties (LTC) at Buy
-
Canaccord Genuity Starts New Senior (SNR) at Buy
-
Canaccord Genuity Starts CareTrust REIT (CTRE) at Buy
-
Canaccord Genuity Starts Physicians Realty Trust (DOC) at Buy
-
Canaccord Genuity Cuts Price Target on ARM Holdings plc (ARMH) Following Soft Android Smartphone Sales
-
Canaccord Genuity Survey Shows Apple (AAPL) iPhone Maintaining Strong High-End Share Despite Global Smartphone Weakness
-
Atara Biotherapeutics (ATRA) Announces $125M Common Stock Offering
-
Atara Bio Announces Proposed Offering of Common Stock
-
ConforMIS Closes Initial Public Offering
-
ConforMIS Closes Initial Public Offering
-
Canaccord Genuity Reiterates Buy on Trupanion (TRUP) Following Survey Results
-
Canaccord Genuity Remains Bullish after Meeting with Level 3 Communications (LVLT) Management
-
Canaccord Genuity Raises Price Target on Versartis (VSAR) as Partial Clinical Hold is Lifted
-
EnteroMedics (ETRM) Prices 32M Common Stock, Warrants Unit Offering at 50c/Unit
-
EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants
-
DHX Media (DHXM) Commences 8.7M Share Offering
-
DHX Media Ltd. Announces Launch of Proposed Public Offering of Shares
-
EnteroMedics (ETRM) Announces Common Stock, Warrants Offering
-
EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants
-
EnteroMedics Inc. Announces Termination of Public Offering of Common Stock and Warrants
-
Bee Vectoring Technologies International Inc. (Formerly Unique Resources Corp.) Announces Commencement of Trading on the TSXV Following Closing of Its Reverse Takeover
-
EMED Mining Public Limited: Notice of AGM
-
EMED Mining Public Limited: Director Share Purchase
-
Canaccord Genuity Cuts Price Target on Xenon Pharmaceuticals (XENE) Following TV-45070 Study
-
Canaccord Genuity Raised Price Target on KemPharm (KMPH) Ahead of KP201 Data
-
Seres Therapeutics Announces Closing of Initial Public Offering
-
ConforMIS (CFMS) IPO Opens Up 20%


